How to buy shares in Miromatrix Medical
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – MIRO – and research it before deciding if it's a...
Full Answer
Where can I buy shares of Miro?
Shares of MIRO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
How much did Miro raise in its IPO?
(MIRO) raised $32 million in an IPO on Thursday, June 24th 2021. The company issued 4,000,000 shares at $7.00-$9.00 per share. Craig-Hallum Capital Group served as the underwriter for the IPO.
Is miromatrix medical (Mir) a good stock to buy?
Miromatrix Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings. According to analysts' consensus price target of $22.00, Miromatrix Medical has a forecasted upside of 458.4% from its current price of $3.94.
Is Miro stock a good investment?
Consensus Rating. Miromatrix Medical has received a consensus rating of Buy.
Who is Miro owned by?
Andrey KhusidBorn in Perm, a city located some 1,150 km east from Moscow, Miro is the brainchild of Andrey Khusid and Oleg Shardin. In the early 2010s, their startup already got recognition from several domestic industry contests, as reported by East-West Digital News.
Is Miro a US company?
Miro is located in San Francisco, California, United States .
What is Miro company worth?
$17.5BVisual collaboration company Miro valued at $17.5B following $400M in new funding.
Is Miro a Microsoft product?
Miro is made for enterprises that collaborate with Microsoft Our security and compliance standards align with the security needs of big enterprises.
Is there anything better than Miro?
Miro is an ace tool in the Remote Whiteboard category. Miro is loved by users for factors like - Free version, Easy-to-use, Team collaboration, Productivity. Lucidspark is the best Miro alternative.
Is Miro public or private?
✏️ Apart from sharing boards publicly, Miro allows invite collaborators via email, enable team/Company/projects access. Learn more in the article Sharing boards and inviting collaborators.
Is Miro a Russian product?
Miro is a US-based corporation, registered in Delaware, with co-headquarters in San Francisco and Amsterdam.
Is Miro a good company?
Is Miro a good company to work for? Miro has an overall rating of 4.5 out of 5, based on over 268 reviews left anonymously by employees. 89% of employees would recommend working at Miro to a friend and 84% have a positive outlook for the business. This rating has decreased by -3% over the last 12 months.
Is Miro a unicorn?
Collaboration startup Miro joins the unicorn club with $400M funding round and $17.5B valuation. Investors continue to throw money at technology aimed at improving collaboration among remote workers. Today, Miro, the business name of RealtimeBoard Inc., said it has closed a $400 million funding.
Who are Miros competitors?
Competitors and Alternatives to MiroZoom Meetings.Webex Suite.Microsoft Teams.BlueJeans Meetings.Google Chat.TeamViewer.GoToMeeting.Adobe Connect.
How many paid users does Miro have?
Since Miro raised its $50M Series B funding round in April 2020, the company has increased its user base by 500% (from 5M to 30M) and its paying customer base by 550% (from 20,000 to 130,000).
What is Miro whiteboard?
Miro offers a collaborative whiteboard platform that is designed to allow distributed teams to work effectively together. Support includes running brainstorming sessions and workshops to planning projects and designing new products and services. Miro has over 7 million users and 20,000 paying customers, including 80% of the Fortune 100. Miro provides seamless integrations with applications like Atlassian JIRA and Confluence, Sketch, Slack, Trello, Box, and Google Drive to support existing workflows of their customers. Miro brings the benefits of a collaborative whiteboard session to everyone in a global company regardless of their location with a secure and scalable solution. The service is available either in a browser or via desktop, Android or iOS app. It can also be used on tablets and interactive whiteboards.
Does Equity Zen have an affiliation with Miro?
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Miro or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
3.5 Analyst's Opinion
Miromatrix Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Is Miromatrix Medical a buy right now?
1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Miromatrix Medical in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Miromatrix Medical stock. View analyst ratings for Miromatrix Medical or view top-rated stocks.
Are investors shorting Miromatrix Medical?
Miromatrix Medical saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 230,200 shares, an increase of 2,156.9% from the December 15th total of 10,200 shares. Based on an average daily volume of 29,500 shares, the days-to-cover ratio is currently 7.8 days.
When is Miromatrix Medical's next earnings date?
Miromatrix Medical is scheduled to release its next quarterly earnings announcement on Monday, February 21st 2022. View our earnings forecast for Miromatrix Medical.
How were Miromatrix Medical's earnings last quarter?
Miromatrix Medical Inc. (NASDAQ:MIRO) posted its quarterly earnings results on Monday, November, 15th. The company reported ($0.25) EPS for the quarter, missing analysts' consensus estimates of ($0.13) by $0.12. The company had revenue of $0.01 million for the quarter. View Miromatrix Medical's earnings history.
What price target have analysts set for MIRO?
1 equities research analysts have issued 1-year price targets for Miromatrix Medical's shares. Their forecasts range from $22.00 to $22.00. On average, they expect Miromatrix Medical's share price to reach $22.00 in the next twelve months.
Who are some of Miromatrix Medical's key competitors?
Some companies that are related to Miromatrix Medical include Autolus Therapeutics (AUTL), Innate Pharma (IPHA), Outlook Therapeutics (OTLK), Curis (CRIS), Taysha Gene Therapies (TSHA), Precision BioSciences (DTIL), Opthea (OPT), BioAtla (BCAB), Oyster Point Pharma (OYST), Poseida Therapeutics (PSTX), Cellectis (CLLS), Passage Bio (PASG), CEL-SCI (CVM), Lineage Cell Therapeutics (LCTX) and Environmental Impact Acquisition (ENVI). View all of MIRO's competitors..
Miromatrix Medical Inc. (MIRO) Company Bio
Miromatrix Medical Inc. engages in the development of biological human organs to solve the chronic shortage of transplantable organs. The company also develops organ-derived biological products for various applications, such as soft tissue reinforcement and wound care.
Miromatrix Announces Participation in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
EDEN PRAIRIE, Minn., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc.
Miromatrix adds Lisa Wipperman Heine, William Burke to board
The company's goal is to scale its organ engineering technology in order to address the shortage of available human organs.
Miromatrix Announces Two New Board Members
EDEN PRAIRIE, Minn., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc.
Miromatrix Medical Inc.s Lock-Up Period Set To End Tomorrow (NASDAQ:MIRO)
Miromatrix Medicals (NASDAQ:MIRO) lock-up period is set to end on Tuesday, December 21st. Miromatrix Medical had issued 4,800,000 shares in its IPO on June 24th. The total size of the offering was $43,200,000 based on an initial share price of $9.00.
Miromatrix Submits Pre-IND Request to the FDA for Its External Liver Assist Product to Treat Acute Liver Failure
The request puts Miromatrix on the path for Phase I IND submission and an in-human trial in 2H2022EDEN PRAIRIE, Minn., Dec. 17, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc.
Miromatrix to Ring Nasdaq Closing Bell on National Donor Day, February 14, 2022
EDEN PRAIRIE, Minn., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, announced that the Company will ring the closing bell at Nasdaq on Monday, February 14, 2022, at 4:00 p.m.
Miromatrix Announces Participation in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
EDEN PRAIRIE, Minn., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc.
Miromatrix adds Lisa Wipperman Heine, William Burke to board
The company's goal is to scale its organ engineering technology in order to address the shortage of available human organs.
